You are here

SARC023

Active
A Phase I/II trial of ganetespib in combination with the mTOR inhibitor sirolimus for patients with unresectable or metastatic malignant peripheral nerve sheath tumors
Type of Sarcoma: 
Phase I all unresectable soft tissue or bone sarcomas and Phase II unresectable malignant peripheral nerve sheath tumor (MPNST)
Drug: 
ganetespib and sirolimus
Accrual Status: 
Open, Not Accruing
Overall Study Principal Investigator: 

AeRang Kim, MD, PhD
Pediatric Oncologist
Children’s National Medical Center

For more information about this trial and open sites: